{"id":190572,"date":"2026-08-07T12:23:17","date_gmt":"2026-08-07T06:53:17","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=190572"},"modified":"2026-08-07T12:23:17","modified_gmt":"2026-08-07T06:53:17","slug":"neuland-laboratories-ltd-share-price-52-week-high-2026-08-07","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/neuland-laboratories-ltd-share-price-52-week-high-2026-08-07\/","title":{"rendered":"Neuland Laboratories Ltd. (NEULANDLAB) Share Price Hits Fresh 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories Ltd.<\/a> rose to Rs 22,452.90, up 4.43% today, after touching a fresh 52-week high of Rs 22,499.95. Market capitalisation stood at Rs 25,614.49 crore.<\/p>\n<p style=\"margin-top:0!important;\">Neuland Laboratories Ltd. Share Price climbed to Rs 22,452.90 on 07 August 2026 at 12:19 PM IST, up Rs 952.95 or 4.43% from the previous close of Rs 21,499.95, after hitting a fresh 52-week high of Rs 22,499.95. The move puts the stock among notable market movers today, with market capitalisation at Rs 25,614.49 crore and turnover at Rs 14.98 crore.<\/p>\n<p>For investors tracking Neuland Laboratories Ltd. Share Price Today, the verified data confirms a clear one-year high event and strong intraday price action. The stock opened at Rs 21,544.20, which was also the day\u2019s low, and then advanced toward the session high of Rs 22,499.95. That price structure matters because it shows gains were built from the opening trade rather than after a deep pullback.<\/p>\n<p>What the supplied data establishes is the price event itself: Neuland Laboratories Ltd. Share Price has registered a fresh 52-week peak on active turnover, making it relevant in today\u2019s stock market today and share market today searches. The data does not establish a company-specific catalyst, but the combination of a new yearly high, a 4.43% gain and a sizeable market cap explains why the stock is trending in Neuland Laboratories Ltd. Stock News and broader market news screens. Univest notes that investors should now monitor whether the stock sustains this level, how valuation compares with the Healthcare benchmark, and how the company stands against listed peers.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Neuland Laboratories Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22,452.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 21,499.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 952.95 (+4.43%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 21,544.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22,499.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 21,544.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6,672<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14.98 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 25,614.49 crore<\/td>\n<\/tr>\n<\/table>\n<p>Neuland Laboratories Ltd. (NEULANDLAB) traded at Rs 22,452.9. versus the previous close of Rs 21,499.95, a rise of 4.43%. The stock opened at Rs 21,544.2, reached Rs 22,499.95, touched Rs 21,544.2. Reported volume was 6,672.<\/p>\n<p>Neuland Laboratories Ltd. Share Price Today reflects a decisive intraday rise from the opening level to a fresh 52-week high, supported by turnover of Rs 14.98 crore and traded volume of 6,672 shares. The session data shows a strong upward range with the low matching the opening print.<\/p>\n<p>From a pure price action perspective, Neuland Laboratories Ltd. Share Price moved from an open of Rs 21,544.20 to a day high of Rs 22,499.95, while the day low also remained at Rs 21,544.20. That means the stock did not slip below its opening level during the reported session window. Against the previous close of Rs 21,499.95, the current price of Rs 22,452.90 represents a gain of Rs 952.95, or 4.43%.<\/p>\n<p>The fresh 52-week high of Rs 22,499.95 sits only marginally above the current price, suggesting the stock was trading close to the top of its intraday range at the time of the update. For traders and long-term market participants alike, that often keeps a stock visible in stocks in news, top gainers today, breakout stocks and 52 week high stocks filters even when the data set does not establish the underlying trigger.<\/p>\n<p>Turnover of Rs 14.98 crore alongside volume of 6,672 shares indicates that the move was accompanied by meaningful value traded, which is often what gives a one-year high greater attention in stock updates and NSE news style coverage. On the supplied data alone, what exactly happened today is straightforward: the stock opened firm, held its opening low, rose to Rs 22,499.95 and continued trading near that 52-week peak. The next step is to examine whether the fundamentals behind this move add support to investor attention.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_Ltd_NEULANDLAB_Fundamental_Analysis\"><\/span><strong>Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 25,614.49 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.46x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<\/table>\n<p>Neuland Laboratories Ltd. was valued at a P\/E ratio of 31.3x, a P\/B ratio of 0.46x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.48x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">72.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 3,493.04x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.46x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.94x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-2.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.75%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 25,614.49 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 140.58 crore<\/td>\n<\/tr>\n<\/table>\n<p>Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare.<\/p>\n<p>Neuland Laboratories Ltd. (NEULANDLAB) has a P\/E ratio of 31.3x, which is above the benchmark median of 21.48x, a difference of +45.72%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Neuland Laboratories Ltd. (NEULANDLAB) has a ROE of -2.89%, which is below the benchmark median of 10.75%, a difference of -126.88%. Neuland Laboratories Ltd. (NEULANDLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,060.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.46<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,652.52<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">40.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.32<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,623.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">67.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,537.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.86<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,290.47<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">167.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<\/table>\n<p>Neuland Laboratories Ltd. (NEULANDLAB) has a P\/E ratio of 31.3x compared with the displayed peer median of 40.87x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 25,614.49 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Neuland_Laboratories_Ltd\"><\/span><strong>Why Investors Are Watching Neuland Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The stock is attracting attention because the supplied data combines a clear price event with valuation and sector contrasts that investors will want to track closely.<\/p>\n<ul>\n<li><strong>Fresh 52-week high:<\/strong> Neuland Laboratories Ltd. Share Price touched Rs 22,499.95 and was trading at Rs 22,452.90, up 4.43% or Rs 952.95 from Rs 21,499.95.<\/li>\n<li><strong>Strong intraday structure:<\/strong> The stock opened at Rs 21,544.20, which was also the day low, showing sustained upward price action through the session.<\/li>\n<li><strong>Meaningful activity:<\/strong> Volume stood at 6,672 shares with turnover of Rs 14.98 crore, enough to keep the move visible in market movers and share news screens.<\/li>\n<li><strong>Large market presence:<\/strong> Market capitalisation is Rs 25,614.49 crore, much larger than the supplied same-sector median of Rs 140.58 crore and average of Rs 471.12 crore.<\/li>\n<li><strong>Mixed valuation-profitability picture:<\/strong> P\/E is 31.3 and P\/B is 0.46, while ROE is -2.89% and ROCE is -0.26%, making the stock a notable case for deeper stock analysis.<\/li>\n<li><strong>Sector context matters:<\/strong> The Healthcare benchmark spans 198 companies, with sector medians of 21.48 for P\/E, 1.94 for P\/B, 10.75% for ROE and 13.29% for ROCE.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Neuland_Laboratories_Ltd\"><\/span><strong>About Neuland Laboratories Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The supplied data identifies Neuland Laboratories Ltd. (NEULANDLAB) as a Healthcare company. Within the comparison sets provided for this article, the stock is being assessed against Healthcare peers and a broader Healthcare benchmark universe of 198 companies. That positioning is what drives the sector and valuation context around the current one-year high.<\/p>\n<p>The peer basket linked to Neuland Laboratories Ltd. includes Healthcare names such as Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd., Dr Agarwals Eye Hospital Ltd. and Sai Parenteral&#8217;s Ltd. Several of those peers are classified in Pharmaceuticals &amp; Drugs, while Dr Agarwals Eye Hospital appears under Hospital &amp; Healthcare Services. This matters because it shows that the supplied market comparison is sector-led rather than narrowly limited to one business line.<\/p>\n<p>For investors following Neuland Laboratories Ltd. Latest News and company news, the most verified takeaway from the present dataset is its market standing: the stock has reached a fresh 52-week high, carries a market cap of Rs 25,614.49 crore and sits within the Healthcare sector framework used for valuation, profitability and peer comparison on Univest.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Neuland_Laboratories_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Neuland Laboratories Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories Ltd. (NEULANDLAB) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors using Univest can track Neuland Laboratories Ltd. Share Price through a single market view that brings together live share price, 52-week levels, market cap, valuation ratios, peer comparison and sector context. For users following Neuland Laboratories Ltd. Share Price Live, that helps connect a fresh yearly high with the underlying numbers that matter.<\/p>\n<p>Univest also helps users monitor Neuland Laboratories Ltd. Share Price Today alongside broader stock performance signals such as intraday movement, turnover, 52 week high and 52 week low positioning, shareholding pattern where available, and comparative market insights. In a session where the stock has become part of stock news, share price update and market trends conversations, keeping the analysis grounded in verified data remains essential. That is especially important when the supplied data confirms the 52-week peak but does not itself identify a company-specific trigger.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Neuland_Laboratories_Ltd_Share_Price_today\"><\/span><strong>What is Neuland Laboratories Ltd. Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories Ltd. Share Price was Rs 22,452.90 at 12:19 PM IST on 07 August 2026. The stock was up Rs 952.95, or 4.43%, from the previous close of Rs 21,499.95.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_Neuland_Laboratories_Ltd_hit_a_fresh_52-week_high_today\"><\/span><strong>Did Neuland Laboratories Ltd. hit a fresh 52-week high today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, the stock touched a fresh 52-week high of Rs 22,499.95 during the session. It was trading close to that level at Rs 22,452.90, which kept the one-year high firmly in focus.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Neuland_Laboratories_Ltd_Share_Price_rising_today\"><\/span><strong>Why is Neuland Laboratories Ltd. Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that the stock rose 4.43% and reached a fresh 52-week high, which explains the attention. However, the verified dataset establishes the price event and does not specify a company-specific catalyst.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_todays_price_action_show_for_Neuland_Laboratories_Ltd\"><\/span><strong>What does today&#39;s price action show for Neuland Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock opened at Rs 21,544.20, which was also the day\u2019s low, and then climbed to Rs 22,499.95. That intraday structure shows sustained upward movement rather than a rebound from lower session levels.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_trading_volume_and_turnover_in_Neuland_Laboratories_Ltd_today\"><\/span><strong>What was the trading volume and turnover in Neuland Laboratories Ltd. today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied session data shows volume of 6,672 shares and turnover of Rs 14.98 crore. Those figures indicate active value traded and help explain why the stock appeared in market movers screens.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Neuland_Laboratories_Ltd\"><\/span><strong>What is the market capitalisation of Neuland Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories Ltd. had a market capitalisation of Rs 25,614.49 crore in the supplied update. That is far above the Healthcare benchmark median of Rs 140.58 crore and average of Rs 471.12 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Neuland_Laboratories_Ltd_expensive_based_on_sector_PE\"><\/span><strong>Is Neuland Laboratories Ltd. expensive based on sector P\/E?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s P\/E ratio is 31.3. That is above the supplied Healthcare sector median of 21.48 but below the sector average of 72.73, placing the stock between the benchmark median and average.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Neuland_Laboratories_Ltd_compare_on_PB_ratio\"><\/span><strong>How does Neuland Laboratories Ltd. compare on P\/B ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock\u2019s P\/B ratio is 0.46, which is below the Healthcare sector median of 1.94 and average of 2.54. On the supplied data, that places it at a lower book-value multiple than the sector benchmark.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_ROE_and_ROCE_indicate_for_Neuland_Laboratories_Ltd\"><\/span><strong>What do ROE and ROCE indicate for Neuland Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ROE stands at -2.89% and ROCE at -0.26% in the supplied dataset. Both figures are below the Healthcare sector medians of 10.75% for ROE and 13.29% for ROCE. ROE stands at -2.89%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_peers_are_being_compared_with_Neuland_Laboratories_Ltd\"><\/span><strong>Which peers are being compared with Neuland Laboratories Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied peer set includes Dishman Carbogen Amcis, Kwality Pharmaceuticals, Beta Drugs, Dr Agarwals Eye Hospital and Sai Parenteral&#39;s. Their market caps range from Rs 2,290.47 crore to Rs 3,060.41 crore.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neuland Laboratories Ltd. Share Price hits a new 52-week high at Rs 22,452.9. marking a 4.43% rise today. Market cap stands at Rs 25,614.49 crore.<\/p>\n","protected":false},"author":29,"featured_media":190569,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-190572","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["190569"],"rank_math_title":["Neuland Laboratories Ltd. Share Price Hits One-Year High"],"rank_math_description":["Neuland Laboratories Ltd. Share Price hit a fresh 52-week high at Rs 22,499.95. Read price action, valuation, sector and peer analysis."],"rank_math_focus_keyword":["Neuland Laboratories Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Neuland_Laboratories_Ltd_NEULANDLAB_Share_Price_Hits_Fresh_52_Week_High_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/190572","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=190572"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/190572\/revisions"}],"predecessor-version":[{"id":190574,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/190572\/revisions\/190574"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/190569"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=190572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=190572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=190572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}